3 photos

• Sort by: number of views (most to least) number of views (least to most) number of comments (most to least) number of comments (least to most) number of favorites (most to least) number of favorites (least to most) date uploaded (newest first) date uploaded (oldest first) random

• Figure 1: Overview of the Interface between States and the Drug Enforcement Administration (DEA) in the Controlled Substance Registration Processes

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 3,282 views
  • Date uploaded: 2016-07-07
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao16310, controlledsubstances, bop, federalbureauofprisons, csa, controlledsubstancesact, csa2, controlledsubstancesdatabase, dea, drugenforcementadministration, di, diversioninvestigator, dmf, deathmasterfile, doj, departmentofjustice, ein, employeridentificationnumber, evs, enumerationverificationsystem, fbi, federalbureauofinvestigation, fsmb, federationofstatemedicalboards, hhs, departmentofhealthandhumanservices, manual, controlledsubstancessecuritymanual, naddis, narcoticsanddangerousdrugsinformationsystem, npdb, nationalpractitionerdatabank, nsor, nationalsexoffenderregistry, od, officeofdiversioncontrol, oig, officeoftheinspectorgeneral, pdmp, prescriptiondrugmonitoringprogram, ssa, socialsecurityadministration, ssn, socialsecuritynumber, usms, unitedstatesmarshalsservice
  • Visibility: public
• Figure 4: Distribution of Critical Shortages of Drugs Containing Controlled Substances by Therapeutic Class and Product Type, January 2001 through June 2013

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 2,086 views
  • Date uploaded: 2015-03-23
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao15202, drugshortages, adhd, attentiondeficithyperactivitydisorder, api, activepharmaceuticalingredient, apq, aggregateproductionquota, arcos, automationofreportsandconsolidatedorderssystem, csa, controlledsubstancesact, dea, drugenforcementadministration, doj, departmentofjusticedssdrugshortagestaff, ems, emergencymedicalservices, fda, foodanddrugadministration, fdasia, foodanddrugadministrationsafetyandinnovationact, gpra, governmentperformanceandresultsactof1993, hhs, departmentofhealthandhumanservices, mou, memorandumofunderstanding, uudis, universityofutahdruginformationservice, yersqms, yearendreportingandquotamanagementsystem
  • Visibility: public
• Figure 1: An Example of the Prescription Drug Supply Chain and Opportunities for Abuse and Diversion

  • Uploaded by: U.S. Government Accountability Office
  • License: United States Government Work
  • 0 comments
  • 0 favorites
  • 1,858 views
  • Date uploaded: 2015-08-28
  • Tags: gao, governmentaccountabilityoffice, usgovernmentaccountabilityoffice, usgao, unitedstatesgovernmentaccountabilityoffice, government, congress, watchdog, oversight, governmentwatchdog, gao15471, prescriptiondrugs, arcos, automatedreportsandconsolidatedorderssystem, cdc, centersfordiseasecontrolandprevention, cms, centersformedicaremedicaidservices, csa, controlledsubstancesact, dea, drugenforcementadministration, pdac, pharmacydiversionawarenessconference
  • Visibility: public